© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Sitafloxacin Monohydrate is a synthetic fluoroquinolone antibacterial agent with strong action against a wide range of bacteria. Its use in healthcare connects directly to the need for newer antibiotics due to rising resistance. The compound stands out for its potency and the chemical structure that lets it fight pathogens where older agents fail. People handling it—whether in research, production, or application—deal with a fine white crystalline powder, sometimes clumped in flakes or granules, sometimes as a dense, gritty material. The form varies depending on drying, storage, and grade, but its solubility and reactivity draw attention in every environment.
The backbone of Sitafloxacin Monohydrate centers on a fluoroquinolone core, offering both rigidity and points for modification. Its empirical formula reads C19H18F2N4O5·H2O, carrying molecular complexity that allows for both water solubility and stability in solid form. Each molecule measures with a molecular weight of about 432.39 g/mol. The water in its monohydrate form brings added stability for transport and storage, which matters to manufacturing and laboratory work. Crystal structure carries repeating units held by hydrogen bonds between the hydrate water molecule and the fluoroquinolone scaffold, a feature that affects solubility and how it dissolves in different solvents.
In practical terms, Sitafloxacin Monohydrate comes to users as a solid powder, not as a liquid or oil. It feels firm between gloved hands, and spills spread quickly in air due to the powder’s low moisture content. Its density measures approximately 1.65 g/cm³, giving it notable heft for such a small molecule. Laboratory test tubes, factory-scale hoppers, and sealed containers might all hold this material—never glossy, not pearlescent, and not oily—just solid, crystalline powder, sometimes loose, sometimes slightly caked depending on atmospheric humidity. Its structure keeps it safe from short bouts of heat at room temperature, yet it loses stability above 200°C, breaking down and releasing odors as it decomposes.
Sitafloxacin Monohydrate comes with a safety record typical of modern antibiotics: beneficial in prescribed amounts, problematic in careless handling. The powder harms if inhaled in dust form, causes irritation on skin or in eyes, and should not be ingested outside medical supervision. Laboratory routines call for nitrile gloves, dust masks, and goggles. Inhaling it over time produces respiratory irritation and, in those with sensitivity, allergic responses. The compound travels labeled as a hazardous raw material under the HS Code 2941.90—just like many controlled pharmaceutical ingredients. Like other synthetic antimicrobials, spills require careful, wet cleaning to prevent dust formation. Waste needs placement in chemical-resistant containers and transport to appropriate disposal sites, never poured down the drain or mixed with general waste.
Open any discussion about Sitafloxacin Monohydrate and questions about raw material quality surface quickly. Pharmaceutical-grade batches use high-purity raw chemicals—each lot documented and quality-checked before use. Properties must line up with registered specifications: purity above 98%, defined water content, and traces of unwanted byproducts like chloroform or heavy metals below strict thresholds. Its use as a raw material in medicine production grows as older drugs stop working against resistant bacteria. Researchers demand reliable sources of the compound—no contaminants, no off-odors, just the pure, solid powder that lets them press forward in the fight against disease. Its role in finished oral tablets and solutions means every kilogram counts, both for health outcomes and for public trust in the medicine that leaves factory doors.
There’s always a need to look at how Sitafloxacin Monohydrate moves from production to the end user. Manufacturing floors use closed systems with negative air pressure and local exhaust to keep powder in check. Regulatory enforcement adds another layer; companies need clean documentation, batch tracking, and third-party analysis for every lot. Warehouses set aside dry, cool storage, well away from acids, oxidizers, or solvents. For those on the front lines—chemists, pharmacists, and quality assurance teams—training plays the main role in safety, covering everything from material safety data to personal protective equipment. Every person handling Sitafloxacin Monohydrate gets the same message: treat it with respect, keep recordkeeping tight, and never take shortcuts with disposal. These steps help ensure the product remains effective in healthcare, while reducing harm to workers and the environment.
Sitafloxacin Monohydrate brings advanced science to the table, filling gaps left by older antibiotics. Anyone working with it—from lab benches to industrial mixers—faces the task of balancing effectiveness and risk, purity and practicality. Choosing good suppliers, storing the product in stable conditions, and honoring safety regulations all come together for the benefit of patients and professionals alike. The focus remains on honest description, chemical integrity, and strict safety—proving that smart, responsible handling of this powerful raw material can lay the groundwork for progress in global healthcare.
